Danny Nedialkova selected as EMBO Young Investigator
Danny Nedialkova, head of the Max Planck Research Group "Mechanisms of Protein Biogenesis" at the Max Planck Institute (MPI) of Biochemistry, has been elected into the EMBO Young Investigator Network. As one of 26 life science researchers chosen this year, she will receive financial support and access to a range of mentoring and training programs for a period of four years, starting in January 2022. "It’s an honor and a privilege to join the Young Investigator network, and I am excited about the new possibilities this opens up for me and my team," says Danny Nedialkova.
“They have already demonstrated scientific excellence despite only recently launching their own laboratories. The EMBO Young Investigator Programme will aid them in taking their career to the next level. We look forward to supporting them during an important phase of their career.” says Michael N. Hall, EMBO Director ad interim. For the synthesis of proteins, the sequence of nucleic acids, the basic building blocks of genetic information, is translated into a specific sequence of amino acids, the basic building blocks of proteins. This is called the genetic code. Danny Nedialkova’s research explores how the genetic code is translated into the thousands of different proteins that make up each cell. Her team uses genome-wide approaches and functional genomics to investigate how protein synthesis is regulated during development and in different cell types.